<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2008</study_start_year><condition>Colorectal Neoplasms</condition><condition>Unresectable or Metastatic Colorectal Cancer</condition><disease>Colorectal Neoplasms</disease><disease>Unresectable Or Metastatic Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2054702</full_dataset_link><location>Japan</location><study_start_month>5</study_start_month><keyword>Irinotecan</keyword><keyword>Sunitinib</keyword><keyword>Levoleucovorin</keyword><keyword>Leucovorin</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Study Of Sunitinib With FOLFIRI In Colorectal Cancer</name><description>To evaluate the efficacy, safety and pharmacokinetics of sunitinib plus FOLFIRI (irinotecan, 5-FU and l-leucovorin) in the first-line treatment of Japanese mCRC patients</description><dates><creation>2008-05-15</creation></dates><accession>2054702</accession><cross_references><ClinicalTrials___gov>NCT00668863</ClinicalTrials___gov></cross_references></HashMap>